SanBio Company Limited
SNBIF
$16.45
$2.1715.20%
OTC PK
| 01/31/2025 | 07/31/2024 | 04/30/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -21.34% | -57.31% | -40.35% | -40.35% | 6.36% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.10% | -50.35% | -59.75% | -59.75% | -49.68% |
| Operating Income | -20.10% | 50.35% | 59.75% | 59.75% | 49.68% |
| Income Before Tax | -19.67% | -14.71% | 109.38% | 109.38% | 85.60% |
| Income Tax Expenses | -584.27% | -159.53% | 186.82% | 186.82% | 97.30% |
| Earnings from Continuing Operations | 9.27% | 10.66% | 79.69% | 79.69% | 81.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.27% | 10.66% | 79.69% | 79.69% | 81.50% |
| EBIT | -20.10% | 50.35% | 59.75% | 59.75% | 49.68% |
| EBITDA | -20.36% | 50.34% | 59.80% | 59.80% | 49.69% |
| EPS Basic | 13.55% | 15.48% | 80.85% | 80.85% | 82.68% |
| Normalized Basic EPS | 6.78% | -8.49% | 108.25% | 108.25% | 83.37% |
| EPS Diluted | 13.55% | 15.48% | 80.85% | 80.85% | 82.68% |
| Normalized Diluted EPS | 6.78% | -8.49% | 108.25% | 108.25% | 83.37% |
| Average Basic Shares Outstanding | 4.99% | 5.74% | 5.86% | 5.86% | 6.78% |
| Average Diluted Shares Outstanding | 4.99% | 5.74% | 5.86% | 5.86% | 6.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |